Estimates based on drug properties and standard treatment parameters.
73.4 mL/min
Moderately Dialyzable
Some removal expected. Half-life: 0.6 hours (telotristat ethyl). Monitor drug levels. Short half-life suggests rapid endogenous clearance may minimize impact of HD.
Data Used:
✅
molar_mass, mw_factor, half_life
⚠️ Missing:
protein_binding, vd
Free fraction:
0.5
Mw factor:
0.85
Vd factor:
0.8
Hl factor:
0.8
Half life:
0.6 hours (telotristat ethyl)
Half life category:
Ultra-short (< 1h)
2.2 mL/min
Low PD Clearance
Minimal removal expected. No supplementation needed. Half-life: 0.6 hours (telotristat ethyl).
Data Used:
✅
molar_mass, half_life
⚠️ Missing:
protein_binding
Free fraction:
0.5
Half life:
0.6 hours (telotristat ethyl)
Half life category:
Ultra-short (< 1h)
Unable to Assess
Insufficient data for TPE risk assessment. Protein binding and Vd required.
Data Used:
✅
half_life
⚠️ Missing:
protein_binding, vd
Half life:
0.6 hours (telotristat ethyl)
Half life category:
Ultra-short (< 1h)
Cannot Assess
Vd data required for hemoadsorption effectiveness assessment.
Data Used:
✅
half_life
⚠️ Missing:
vd
Half life:
0.6 hours (telotristat ethyl)
Half life category:
Ultra-short (< 1h)
